R Scott McClelland1, Barbra A Richardson, Peter Cherutich, Kishorchandra Mandaliya, Grace John-Stewart, Benard Miregwa, Katherine Odem-Davis, Walter Jaoko, Davies Kimanga, Julie Overbaugh. 1. aDepartment of Medicine bDepartment of Epidemiology cDepartment of Global Health dDepartment of Biostatistics, University of Washington, Seattle, Washington, USA eInstitute of Tropical and Infectious Diseases fDepartment of Medical Microbiology, University of Nairobi, Nairobi, Kenya gDivision of Human Biology hDivision of Public Health Sciences iDivision of Vaccine and Infectious Disease, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA jNational AIDS and STD Control Programme, Nairobi kMombasa County Department of Policy and Research, Mombasa, Kenya.
Abstract
OBJECTIVE: To test the hypothesis that increasing community antiretroviral therapy (ART) coverage would be associated with lower HIV incidence in female sex workers (FSWs) in Mombasa District, Kenya. DESIGN: Prospective cohort study. METHODS: From 1998 to 2012, HIV-negative FSWs were asked to return monthly for an interview regarding risk behavior and testing for sexually transmitted infections including HIV. We evaluated the association between community ART coverage and FSW's risk of becoming HIV infected using Cox proportional hazards models adjusted for potential confounding factors. RESULTS: One thousand, four hundred and four FSWs contributed 4335 woman-years of follow-up, with 145 acquiring HIV infection (incidence 3.35/100 woman-years). The ART rollout began in 2003. By 2012, an estimated 52% of HIV-positive individuals were receiving treatment. Community ART coverage was inversely associated with HIV incidence (adjusted hazard ratio 0.77; 95% confidence interval 0.61-0.98; P = 0.03), suggesting that each 10% increase in coverage was associated with a 23% reduction in FSWs' risk of HIV acquisition. Community ART coverage had no impact on herpes simplex virus type-2 incidence (adjusted hazard ratio 0.97; 95% confidence interval 0.79-1.20; P = 0.8). CONCLUSION: Increasing general population ART coverage was associated with lower HIV incidence in FSWs. The association with HIV incidence, but not herpes simplex virus type-2 incidence, suggests that the effect of community ART coverage may be specific to HIV. Interventions such as preexposure prophylaxis and antiretroviral-containing microbicides have produced disappointing results in HIV prevention trials with FSWs. These results suggest that FSWs' risk of acquiring HIV infection might be reduced through the indirect approach of increasing ART coverage in the community.
OBJECTIVE: To test the hypothesis that increasing community antiretroviral therapy (ART) coverage would be associated with lower HIV incidence in female sex workers (FSWs) in Mombasa District, Kenya. DESIGN: Prospective cohort study. METHODS: From 1998 to 2012, HIV-negative FSWs were asked to return monthly for an interview regarding risk behavior and testing for sexually transmitted infections including HIV. We evaluated the association between community ART coverage and FSW's risk of becoming HIV infected using Cox proportional hazards models adjusted for potential confounding factors. RESULTS: One thousand, four hundred and four FSWs contributed 4335 woman-years of follow-up, with 145 acquiring HIV infection (incidence 3.35/100 woman-years). The ART rollout began in 2003. By 2012, an estimated 52% of HIV-positive individuals were receiving treatment. Community ART coverage was inversely associated with HIV incidence (adjusted hazard ratio 0.77; 95% confidence interval 0.61-0.98; P = 0.03), suggesting that each 10% increase in coverage was associated with a 23% reduction in FSWs' risk of HIV acquisition. Community ART coverage had no impact on herpes simplex virus type-2 incidence (adjusted hazard ratio 0.97; 95% confidence interval 0.79-1.20; P = 0.8). CONCLUSION: Increasing general population ART coverage was associated with lower HIV incidence in FSWs. The association with HIV incidence, but not herpes simplex virus type-2 incidence, suggests that the effect of community ART coverage may be specific to HIV. Interventions such as preexposure prophylaxis and antiretroviral-containing microbicides have produced disappointing results in HIV prevention trials with FSWs. These results suggest that FSWs' risk of acquiring HIV infection might be reduced through the indirect approach of increasing ART coverage in the community.
Authors: Quarraisha Abdool Karim; Salim S Abdool Karim; Janet A Frohlich; Anneke C Grobler; Cheryl Baxter; Leila E Mansoor; Ayesha B M Kharsany; Sengeziwe Sibeko; Koleka P Mlisana; Zaheen Omar; Tanuja N Gengiah; Silvia Maarschalk; Natasha Arulappan; Mukelisiwe Mlotshwa; Lynn Morris; Douglas Taylor Journal: Science Date: 2010-07-19 Impact factor: 47.728
Authors: Robert M Grant; Javier R Lama; Peter L Anderson; Vanessa McMahan; Albert Y Liu; Lorena Vargas; Pedro Goicochea; Martín Casapía; Juan Vicente Guanira-Carranza; Maria E Ramirez-Cardich; Orlando Montoya-Herrera; Telmo Fernández; Valdilea G Veloso; Susan P Buchbinder; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Kenneth H Mayer; Esper Georges Kallás; K Rivet Amico; Kathleen Mulligan; Lane R Bushman; Robert J Hance; Carmela Ganoza; Patricia Defechereux; Brian Postle; Furong Wang; J Jeff McConnell; Jia-Hua Zheng; Jeanny Lee; James F Rooney; Howard S Jaffe; Ana I Martinez; David N Burns; David V Glidden Journal: N Engl J Med Date: 2010-11-23 Impact factor: 91.245
Authors: Joshua Kimani; Rupert Kaul; Nico J D Nagelkerke; Ma Luo; Kelly S MacDonald; Elizabeth Ngugi; Keith R Fowke; Blake T Ball; Anthony Kariri; Jeckoniah Ndinya-Achola; Francis A Plummer Journal: AIDS Date: 2008-01-02 Impact factor: 4.177
Authors: J M Baeten; B A Richardson; H L Martin; P M Nyange; L Lavreys; E N Ngugi; K Mandaliya; J O Ndinya-Achola; J J Bwayo; J K Kreiss Journal: J Acquir Immune Defic Syndr Date: 2000-08-15 Impact factor: 3.731
Authors: Julio S G Montaner; Viviane D Lima; Rolando Barrios; Benita Yip; Evan Wood; Thomas Kerr; Kate Shannon; P Richard Harrigan; Robert S Hogg; Patricia Daly; Perry Kendall Journal: Lancet Date: 2010-07-16 Impact factor: 79.321
Authors: Moupali Das; Priscilla Lee Chu; Glenn-Milo Santos; Susan Scheer; Eric Vittinghoff; Willi McFarland; Grant N Colfax Journal: PLoS One Date: 2010-06-10 Impact factor: 3.240
Authors: Christopher D Pilcher; Hsiao Chuan Tien; Joseph J Eron; Pietro L Vernazza; Szu-Yun Leu; Paul W Stewart; Li-Ean Goh; Myron S Cohen Journal: J Infect Dis Date: 2004-04-28 Impact factor: 5.226
Authors: Stanley Luchters; Matthew F Chersich; Agnes Rinyiru; Mary-Stella Barasa; Nzioki King'ola; Kishorchandra Mandaliya; Wilkister Bosire; Sam Wambugu; Peter Mwarogo; Marleen Temmerman Journal: BMC Public Health Date: 2008-04-29 Impact factor: 3.295
Authors: Xiangrong Kong; Godfrey Kigozi; Joseph Ssekasanvu; Fred Nalugoda; Gertrude Nakigozi; Anthony Ndyanabo; Tom Lutalo; Steven J Reynolds; Robert Ssekubugu; Joseph Kagaayi; Eva Bugos; Larry W Chang; Pilgrim Nanlesta; Grabowski Mary; Amanda Berman; Thomas C Quinn; David Serwadda; Maria J Wawer; Ronald H Gray Journal: JAMA Date: 2016-07-12 Impact factor: 56.272
Authors: Michelle C Sabo; Dara A Lehman; Bingjie Wang; Barbra A Richardson; Sujatha Srinivasan; Lusi Osborn; Daniel Matemo; John Kinuthia; Tina L Fiedler; Matthew M Munch; Alison L Drake; David N Fredricks; Julie Overbaugh; Grace John-Stewart; R Scott McClelland; Susan M Graham Journal: Sex Transm Infect Date: 2019-06-13 Impact factor: 3.519
Authors: Olamide D Jarrett; Sujatha Srinivasan; Barbra A Richardson; Tina Fiedler; Jacqueline M Wallis; John Kinuthia; Walter Jaoko; Kishor Mandaliya; David N Fredricks; R Scott McClelland Journal: J Infect Dis Date: 2019-09-26 Impact factor: 5.226
Authors: Sylvia M LaCourse; Ruth W Deya; Susan M Graham; Linnet N Masese; Walter Jaoko; Kischorchandra N Mandaliya; Julie Overbaugh; R Scott McClelland Journal: J Acquir Immune Defic Syndr Date: 2017-09-01 Impact factor: 3.731
Authors: R Scott McClelland; Jairam R Lingappa; Sujatha Srinivasan; John Kinuthia; Grace C John-Stewart; Walter Jaoko; Barbra A Richardson; Krista Yuhas; Tina L Fiedler; Kishorchandra N Mandaliya; Matthew M Munch; Nelly R Mugo; Craig R Cohen; Jared M Baeten; Connie Celum; Julie Overbaugh; David N Fredricks Journal: Lancet Infect Dis Date: 2018-01-26 Impact factor: 25.071
Authors: Erica M Lokken; Barbra A Richardson; John Kinuthia; Khamis Mwinyikai; Amina Abdalla; Walter Jaoko; Kishorchandra Mandaliya; Juma Shafi; R Scott McClelland Journal: Sex Transm Dis Date: 2019-01 Impact factor: 2.830
Authors: Sarah T Roberts; Brian P Flaherty; Ruth Deya; Linnet Masese; Jacqueline Ngina; R Scott McClelland; Jane Simoni; Susan M Graham Journal: AIDS Behav Date: 2018-10
Authors: Alexandra C Willcox; Barbra A Richardson; Juma Shafi; Emmanuel Kabare; John Kinuthia; Walter Jaoko; Kishorchandra Mandaliya; Julie Overbaugh; R Scott McClelland Journal: AIDS Behav Date: 2021-04-16
Authors: Erica M Lokken; George Wanje; Barbra A Richardson; Esther Mutunga; Kate S Wilson; Walter Jaoko; John Kinuthia; Raymond Scott McClelland Journal: J Acquir Immune Defic Syndr Date: 2020-09-01 Impact factor: 3.771